Heron Therapeutics Inc (HRTX)
1.245
+0.04
(+2.89%)
USD |
NASDAQ |
Nov 14, 16:00
1.25
0.00 (0.00%)
After-Hours: 20:00
Heron Therapeutics Enterprise Value: 290.40M for Nov. 13, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 13, 2024 | 290.40M |
| November 12, 2024 | 301.02M |
| November 11, 2024 | 385.95M |
| November 08, 2024 | 372.30M |
| November 07, 2024 | 375.33M |
| November 06, 2024 | 379.88M |
| November 05, 2024 | 375.33M |
| November 04, 2024 | 376.85M |
| November 01, 2024 | 376.85M |
| October 31, 2024 | 370.78M |
| October 30, 2024 | 379.88M |
| October 29, 2024 | 375.33M |
| October 28, 2024 | 396.57M |
| October 25, 2024 | 387.47M |
| October 24, 2024 | 376.85M |
| October 23, 2024 | 379.88M |
| October 22, 2024 | 376.85M |
| October 21, 2024 | 381.40M |
| October 18, 2024 | 373.82M |
| October 17, 2024 | 382.92M |
| October 16, 2024 | 390.50M |
| October 15, 2024 | 379.88M |
| October 14, 2024 | 378.37M |
| October 11, 2024 | 385.95M |
| October 10, 2024 | 382.92M |
| Date | Value |
|---|---|
| October 09, 2024 | 388.98M |
| October 08, 2024 | 398.08M |
| October 07, 2024 | 404.15M |
| October 04, 2024 | 428.42M |
| October 03, 2024 | 420.83M |
| October 02, 2024 | 423.87M |
| October 01, 2024 | 410.22M |
| September 30, 2024 | 408.70M |
| September 27, 2024 | 408.70M |
| September 26, 2024 | 417.80M |
| September 25, 2024 | 393.53M |
| September 24, 2024 | 404.15M |
| September 23, 2024 | 407.18M |
| September 20, 2024 | 419.32M |
| September 19, 2024 | 413.25M |
| September 18, 2024 | 402.63M |
| September 17, 2024 | 395.05M |
| September 16, 2024 | 384.43M |
| September 13, 2024 | 390.50M |
| September 12, 2024 | 385.95M |
| September 11, 2024 | 381.40M |
| September 10, 2024 | 382.92M |
| September 09, 2024 | 381.40M |
| September 06, 2024 | 379.88M |
| September 05, 2024 | 379.88M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
177.09M
Minimum
Nov 14 2023
2.145B
Maximum
Dec 03 2019
792.85M
Average
606.37M
Median
Enterprise Value Benchmarks
| Journey Medical Corp | 102.58M |
| NovaBay Pharmaceuticals Inc | 3.432M |
| Palatin Technologies Inc | 13.74M |
| iBio Inc | 6.814M |
| Theriva Biologics Inc | -13.26M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -9.235M |
| Revenue (Quarterly) | 36.02M |
| Total Expenses (Quarterly) | 42.47M |
| EPS Diluted (Quarterly) | -0.06 |
| Gross Profit Margin (Quarterly) | 70.80% |
| Profit Margin (Quarterly) | -25.64% |
| Earnings Yield | -24.10% |
| Normalized Earnings Yield | -24.10 |